Sensitive quantification of somatic mutations using molecular inversion probes

Rena Hirani, Ashley Connolly, Lisa Putral, Alexander Dobrovic, Matt Trau

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)


    Somatic mutations in DNA can serve as cancer specific biomarkers and are increasingly being used to direct treatment. However, they can be difficult to detect in tissue biopsies because there is often only a minimal amount of sample and the mutations are often masked by the presence of wild type alleles from nontumor material in the sample. To facilitate the sensitive and specific analysis of DNA mutations in tissues, a multiplex assay capable of detecting nucleotide changes in less than 150 cells was developed. The assay extends the application of molecular inversion probes to enable sensitive discrimination and quantification of nucleotide mutations that are present in less than 0.1% of a cell population. The assay was characterized by detecting selected mutations in the KRAS gene, which has been implicated in up to 25% of all cancers. These mutations were detected in a single multiplex assay by incorporating the rapid flow cytometric readout of multiplexable DNA biosensors.

    Original languageEnglish
    Pages (from-to)8215-8221
    Number of pages7
    JournalAnalytical Chemistry
    Issue number21
    Publication statusPublished - 1 Nov 2011


    Dive into the research topics of 'Sensitive quantification of somatic mutations using molecular inversion probes'. Together they form a unique fingerprint.

    Cite this